European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision

A European Federation of Neurological Societies/Peripheral Nerve Society consensus guideline on the definition, investigation, and treatment of multifocal motor neuropathy (MMN) was published in 2006. The aim is to revise this guideline. Disease experts considered references retrieved from MEDLINE and Cochrane Systematic Reviews published between August 2004 and July 2009 and prepared statements that were agreed to in an iterative fashion. The Task Force agreed on Good Practice Points to define clinical and electrophysiological diagnostic criteria for MMN, investigations to be considered, and principal recommendations for treatment.

[1]  Belgium,et al.  European Federation of Neurological Societies/Peripheral Nerve Society Guideline * on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision , 2010, Journal of the peripheral nervous system : JPNS.

[2]  D. Cocito,et al.  Oral methotrexate as adjunctive therapy in patients with multifocal motor neuropathy on chronic IVIg therapy , 2009, Journal of the peripheral nervous system : JPNS.

[3]  F. Aichner,et al.  Beneficial effect of rituximab monotherapy in multifocal motor neuropathy , 2009, Neuromuscular Disorders.

[4]  L. H. van den Berg,et al.  Subcutaneous immunoglobulin therapy for multifocal motor neuropathy , 2009, Journal of the peripheral nervous system : JPNS.

[5]  J. Jakobsen,et al.  Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single‐blinded cross‐over trial , 2009, European journal of neurology.

[6]  C. Hess,et al.  IVIg dose increase in multifocal motor neuropathy , 2009, Journal of Neurology.

[7]  T. Maisonobe,et al.  Neuropathie motrice multifocale : existe-t-il une altération de la conduction sensitive au long cours ? Une étude rétrospective chez 21 patients , 2009 .

[8]  V. Lambrecq,et al.  Sensory loss in multifocal motor neuropathy: A clinical and electrophysiological study , 2009, Muscle & nerve.

[9]  H. Hartung,et al.  The clinical value of therapeutic plasma exchange in multifocal motor neuropathy , 2008, Journal of the Neurological Sciences.

[10]  T. Maisonobe,et al.  Intravenous immunoglobulin as short- and long-term therapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[11]  L. H. van den Berg,et al.  Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial. , 2007, Brain : a journal of neurology.

[12]  R. Weinstein,et al.  Rituximab treatment in patients with IVIg‐dependent immune polyneuropathy: A prospective pilot trial , 2007, Muscle & nerve.

[13]  M. Slee,et al.  Multifocal motor neuropathy , 2007, Neurology.

[14]  L. H. van den Berg,et al.  Criteria for conduction block based on computer simulation studies of nerve conduction with human data obtained in the forearm segment of the median nerve. , 2006, Brain : a journal of neurology.

[15]  J. Pouget,et al.  Multifocal motor neuropathy with and without conduction block , 2006, Neurology.

[16]  K. Nakamura,et al.  Activity-dependent conduction block in multifocal motor neuropathy. , 2000, Brain : a journal of neurology.

[17]  C. Polman,et al.  Axon loss is an important determinant of weakness in multifocal motor neuropathy , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[18]  A. Priori,et al.  Multifocal motor neuropathy: Current concepts and controversies , 2005, Muscle & nerve.

[19]  G. Zenebe,et al.  Neurologic services in the nations of Africa , 2005, Neurology.

[20]  P. Fuhr,et al.  Rituximab stabilizes multifocal motor neuropathy increasingly less responsive to IVIg , 2004, Neurology.

[21]  S. Vucic,et al.  Multifocal motor neuropathy , 2004, Neurology.

[22]  S. Barbieri,et al.  How long is IVIg effective in multifocal motor neuropathy? , 2004, Neurology.

[23]  R. Rojas-García,et al.  Chronic neuropathy with IgM anti-ganglioside antibodies: Lack of long term response to rituximab , 2003, Neurology.

[24]  K. Oshimi,et al.  Multifocal motor neuropathy caused by a B‐cell lymphoma producing a monoclonal IgM autoantibody against peripheral nerve myelin glycolipids GM1 and GD1b , 2003, British journal of haematology.

[25]  E. Calabrese,et al.  Efficacy of cyclosporine treatment in multifocal motor neuropathy , 2003, Journal of Neurology.

[26]  Ryuji Kaji,et al.  Physiology of conduction block in multifocal motor neuropathy and other demyelinating neuropathies , 2003, Muscle & nerve.

[27]  R. Lewis,et al.  Consensus criteria for the diagnosis of multifocal motor neuropathy , 2003, Muscle & nerve.

[28]  L. H. van den Berg,et al.  Demyelination and axonal loss in multifocal motor neuropathy: distribution and relation to weakness. , 2003, Brain : a journal of neurology.

[29]  H. Willison,et al.  Peripheral neuropathies and anti-glycolipid antibodies. , 2002, Brain : a journal of neurology.

[30]  F. Trimarchi,et al.  Multifocal motor neuropathy and asymptomatic Hashimoto's thyroiditis: first report of an association , 2002, Neuromuscular Disorders.

[31]  R. Schwartzman,et al.  High-dose cyclophosphamide without stem-cell rescue for refractory CIDP , 2002, Neurology.

[32]  L. H. van den Berg,et al.  Mimic syndromes in sporadic cases of progressive spinal muscular atrophy , 2002, Neurology.

[33]  E. Nobile‐Orazio.  Multifocal motor neuropathy , 2001, Journal of Neuroimmunology.

[34]  P. R. A. C. Hughes,et al.  79th ENMC International Workshop: Multifocal motor neuropathy 14–15 April 2000, Hilversum, The Netherlands , 2001, Neuromuscular Disorders.

[35]  V. Meininger,et al.  Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study. , 2001, Brain : a journal of neurology.

[36]  L. H. van den Berg,et al.  Multifocal motor neuropathy: Diagnostic criteria that predict the response to immunoglobulin treatment , 2000, Annals of neurology.

[37]  W. Brown,et al.  Multifocal motor neuropathy improved by IVIg , 2000, Neurology.

[38]  P. Dyck,et al.  Natural history of 46 patients with multifocal motor neuropathy with conduction block , 2000, Muscle & nerve.

[39]  L. H. van den Berg,et al.  Treatment of multifocal motor neuropathy with interferon-β1A , 2000, Neurology.

[40]  D. Claus,et al.  Plasmapheresis in multifocal motor neuropathy: a case report , 2000, Journal of neurology, neurosurgery, and psychiatry.

[41]  G. Jansen,et al.  Multifocal inflammatory demyelinating neuropathy , 2000, Neurology.

[42]  R. Lewis.  Multifocal motor neuropathy and Lewis Sumner syndrome: Two distinct entities , 1999, Muscle & nerve.

[43]  J. Kimura,et al.  Multifocal motor neuropathy and Lewis Sumner syndrome: A clinical spectrum , 1999, Muscle & nerve.

[44]  J. Molinuevo,et al.  Central motor conduction time in patients with multifocal motor conduction block , 1999, Muscle & nerve.

[45]  C. Shaw,et al.  Use of human intravenous immunoglobulin in lower motor neuron syndromes , 1999, Journal of neurology, neurosurgery, and psychiatry.

[46]  D. Burns,et al.  Multifocal acquired demyelinating sensory and motor neuropathy: The Lewis–Sumner syndrome , 1999, Muscle & nerve.

[47]  G. Parry.  Are multifocal motor neuropathy and Lewis–Sumner syndrome distinct nosologic entities? , 1999, Muscle & nerve.

[48]  J. Meulstee,et al.  Chronic motor neuropathies: response to interferon-β1a after failure of conventional therapies , 1999, Journal of neurology, neurosurgery, and psychiatry.

[49]  S. Beydoun,et al.  Multifocal motor neuropathy with conduction block misdiagnosed as multiple entrapment neuropathies , 1998, Muscle & nerve.

[50]  S. Barbieri,et al.  Deterioration of multifocal motor neuropathy after plasma exchange , 1998, Neurology.

[51]  L. H. van den Berg,et al.  The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy. , 1998, Brain : a journal of neurology.

[52]  G. Parry,et al.  Multifocal motor neuropathy without overt conduction block , 1998, Muscle & nerve.

[53]  S. Barbieri,et al.  Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy , 1997, Journal of neurology, neurosurgery, and psychiatry.

[54]  L. H. van den Berg,et al.  Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy , 1997, Neurology.

[55]  L. H. van den Berg,et al.  Pulsed high‐dose dexamethasone is not effective in patients with multifocal motor neuropathy , 1997, Neurology.

[56]  O. Blin,et al.  Long term follow up of multifocal motor neuropathy with conduction block under treatment. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[57]  D. S. Kim,et al.  Motor and sensory demyelinating mononeuropathy multiplex (multifocal motor and sensory demyelinating neuropathy): a separate entity or a variant of chronic inflammatory demyelinating polyneuropathy? , 1997, Journal of the peripheral nervous system : JPNS.

[58]  A. Windebank,et al.  The sensitivity and specificity of anti-GM sub 1 antibody testing , 1996, Neurology.

[59]  T. Crawford,et al.  Sensory nerve pathology in multifocal motor neuropathy , 1996, Annals of neurology.

[60]  W. Robberecht,et al.  Pathological findings in a patient with amyotrophic lateral sclerosis and multifocal motor neuropathy with conduction block , 1996, Journal of the Neurological Sciences.

[61]  L. H. van den Berg,et al.  Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[62]  A. Brand,et al.  Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies , 1995, Neurology.

[63]  V. Meininger,et al.  Multifocal motor neuropathy with conduction block: a study of 24 patients. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[64]  O. Blin,et al.  Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti‐GM1 antibodies , 1994, Neurology.

[65]  G. Parry,et al.  Motor Neuropathy with Multifocal Conduction Block , 1993, Seminars in neurology.

[66]  Robert G. Miller,et al.  Multifocal motor neuropathy: Response to human immune globulin , 1993 .

[67]  A. Pestronk,et al.  Immunosuppressive treatment in multifocal motor neuropathy , 1991, Annals of neurology.

[68]  W. Brown,et al.  Conduction block in clinical practice , 1991, Muscle & nerve.

[69]  I. Hausmanowa-Petrusewicz,et al.  Chronic acquired demyelinating motor neuropathy , 1991, Acta neurologica Scandinavica.

[70]  J. England,et al.  A computer simulation of conduction block: Effects produced by actual block versus interphase cancellation , 1990, Annals of neurology.

[71]  A. Pestronk,et al.  Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies , 1990, Annals of neurology.

[72]  S. Lipton,et al.  A syndrome of asymmetric limb weakness with motor conduction block , 1990, Neurology.

[73]  A. Pestronk,et al.  A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside , 1988, Annals of neurology.

[74]  G. Parry,et al.  Multifocal acquired demyelinating neuropathy masqurading as motor neuron disease , 1988, Muscle & nerve.

[75]  D. Chad,et al.  Slow resolution of multifocal weakness and fasciculation , 1986, Neurology.

[76]  M. Magistris,et al.  Motor neuropathy with proximal multifocal persistent conduction block, fasciculations and myokymia. Evolution to tetraplegia. , 1986, European neurology.